...transaction involving 263,158 newly issued PPDI shares. PPDI, a contract research organization, also will acquire Ingenex's... ...subsidiary. Ingenex is a majority-owned subsidiary of Titan Pharmaceuticals Inc. (TTNP, South San Francisco, Calif.). Ingenex Inc....
...263,158 newly issued shares of PPDI worth about $5.1 million. PPDI also will acquire from Ingenex Inc.... ...GSX System functional genomics technology, including associated facilities and personnel, for $8.7 million in cash. Ingenex... ...Calif.). Both platforms will be incorporated into a new, unnamed PPDI subsidiary run by former Ingenex...
...the antiviral company, which is heavily laden with former Wellcome managers and researchers. PLUG PULLED: Ingenex Inc.... ...the shares at $8.50-$9.50. TTNP was to purchase 222,222 shares to increase its ownership in Ingenex...
...million had the deal priced at $11.50. KDUS closed the week at $7.375. MARKET HOPEFULS: Ingenex Inc.... ...price would give the gene therapy company (Menlo Park, Calif.) a $27 million market cap. Ingenex's... ...an option to purchase 222,222 shares in the offering, which would increase its ownership in Ingenex...
...TTNP's Ingenex Inc. subsidiary received a $750,000 Phase II SBIR grant from the National Institutes of Allergy... ...discover and characterize gene fragments that appear capable of interfering with the replication of HIV. Ingenex...
...genes that may be involved in the disease. GSEs are DNA, RNA or peptide fragments. Ingenex... ...improve the methods researchers use to identify regulatory elements capable of suppressing any biologic process. Ingenex Inc....
Ingenex Inc. , Menlo Park, Calif. Product: MDR-1 gene delivered ex vivo to blood precursor cells by a retroviral vector Indication: Protection of marrow and blood in chemotherapy Status: Began pilot trial in 10 patients with...
...transaction involving 263,158 newly issued PPDI shares. PPDI, a contract research organization, also will acquire Ingenex's... ...subsidiary. Ingenex is a majority-owned subsidiary of Titan Pharmaceuticals Inc. (TTNP, South San Francisco, Calif.). Ingenex Inc....
...263,158 newly issued shares of PPDI worth about $5.1 million. PPDI also will acquire from Ingenex Inc.... ...GSX System functional genomics technology, including associated facilities and personnel, for $8.7 million in cash. Ingenex... ...Calif.). Both platforms will be incorporated into a new, unnamed PPDI subsidiary run by former Ingenex...
...the antiviral company, which is heavily laden with former Wellcome managers and researchers. PLUG PULLED: Ingenex Inc.... ...the shares at $8.50-$9.50. TTNP was to purchase 222,222 shares to increase its ownership in Ingenex...
...million had the deal priced at $11.50. KDUS closed the week at $7.375. MARKET HOPEFULS: Ingenex Inc.... ...price would give the gene therapy company (Menlo Park, Calif.) a $27 million market cap. Ingenex's... ...an option to purchase 222,222 shares in the offering, which would increase its ownership in Ingenex...
...TTNP's Ingenex Inc. subsidiary received a $750,000 Phase II SBIR grant from the National Institutes of Allergy... ...discover and characterize gene fragments that appear capable of interfering with the replication of HIV. Ingenex...
...genes that may be involved in the disease. GSEs are DNA, RNA or peptide fragments. Ingenex... ...improve the methods researchers use to identify regulatory elements capable of suppressing any biologic process. Ingenex Inc....
Ingenex Inc. , Menlo Park, Calif. Product: MDR-1 gene delivered ex vivo to blood precursor cells by a retroviral vector Indication: Protection of marrow and blood in chemotherapy Status: Began pilot trial in 10 patients with...
